Literature DB >> 15566303

Time-related differences in the physical property profiles of oral drugs.

Paul D Leeson1, Andrew M Davis.   

Abstract

Comparisons of the calculated physicochemical properties of oral drugs launched prior to 1983 (864 drugs) and between 1983 and 2002 (329 drugs) show that mean values of lipophilicity, percent polar surface area and H-bond donor count are the same, suggesting that these are the most important oral druglike physical properties. In contrast, mean values of molecular weight and the numbers of O + N atoms, H-bond acceptors, and rotatable bonds and rings have increased in 1983-2002 drugs (by 13-29%). Analysis of the 1983-2002 oral drugs by therapy area shows that antiinfectives and nervous system drugs have the most extreme physical property profiles. Cardiovascular drugs show increasing molecular weight with year of publication, primarily a consequence of focusing on clinically proven mechanisms, with limited chemical diversity. Drug classes other than antiinfectives show comparable distributions of lipophilicity, suggesting that this property in oral drugs is important irrespective of the drug's target. The results suggest that the balance between polar and nonpolar drug properties is an important, unchanging feature of oral drug molecules.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15566303     DOI: 10.1021/jm049717d

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  37 in total

Review 1.  Finding the sweet spot: the role of nature and nurture in medicinal chemistry.

Authors:  Michael M Hann; György M Keserü
Journal:  Nat Rev Drug Discov       Date:  2012-04-30       Impact factor: 84.694

Review 2.  The influence of the 'organizational factor' on compound quality in drug discovery.

Authors:  Paul D Leeson; Stephen A St-Gallay
Journal:  Nat Rev Drug Discov       Date:  2011-09-30       Impact factor: 84.694

3.  Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes.

Authors:  Travis T Wager; Ramalakshmi Y Chandrasekaran; Xinjun Hou; Matthew D Troutman; Patrick R Verhoest; Anabella Villalobos; Yvonne Will
Journal:  ACS Chem Neurosci       Date:  2010-03-25       Impact factor: 4.418

Review 4.  Chemical predictive modelling to improve compound quality.

Authors:  John G Cumming; Andrew M Davis; Sorel Muresan; Markus Haeberlein; Hongming Chen
Journal:  Nat Rev Drug Discov       Date:  2013-12       Impact factor: 84.694

Review 5.  The role of ligand efficiency metrics in drug discovery.

Authors:  Andrew L Hopkins; György M Keserü; Paul D Leeson; David C Rees; Charles H Reynolds
Journal:  Nat Rev Drug Discov       Date:  2014-02       Impact factor: 84.694

6.  Optimization of Pharmacokinetics through Manipulation of Physicochemical Properties in a Series of HCV Inhibitors.

Authors:  Scott E Lazerwith; Gina Bahador; Eda Canales; Guofeng Cheng; Lee Chong; Michael O Clarke; Edward Doerffler; Eugene J Eisenberg; Jaclyn Hayes; Bing Lu; Qi Liu; Mike Matles; Michael Mertzman; Michael L Mitchell; Philip Morganelli; Bernard P Murray; Margaret Robinson; Robert G Strickley; Megan Tessler; Neeraj Tirunagari; Jianhong Wang; Yujin Wang; Jennifer R Zhang; Xubin Zheng; Weidong Zhong; William J Watkins
Journal:  ACS Med Chem Lett       Date:  2011-08-08       Impact factor: 4.345

7.  Physicochemical Properties, Biotransformation, and Transport Pathways of Established and Newly Approved Medications: A Systematic Review of the Top 200 Most Prescribed Drugs vs. the FDA-Approved Drugs Between 2005 and 2016.

Authors:  Anitha Saravanakumar; Armin Sadighi; Rachel Ryu; Fatemeh Akhlaghi
Journal:  Clin Pharmacokinet       Date:  2019-10       Impact factor: 6.447

8.  Property-based design of a glucosylceramide synthase inhibitor that reduces glucosylceramide in the brain.

Authors:  Scott D Larsen; Michael W Wilson; Akira Abe; Liming Shu; Christopher H George; Paul Kirchhoff; H D Hollis Showalter; Jianming Xiang; Richard F Keep; James A Shayman
Journal:  J Lipid Res       Date:  2011-11-04       Impact factor: 5.922

9.  Cheminformatic comparison of approved drugs from natural product versus synthetic origins.

Authors:  Christopher F Stratton; David J Newman; Derek S Tan
Journal:  Bioorg Med Chem Lett       Date:  2015-07-14       Impact factor: 2.823

10.  Physiochemical property space distribution among human metabolites, drugs and toxins.

Authors:  Varun Khanna; Shoba Ranganathan
Journal:  BMC Bioinformatics       Date:  2009-12-03       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.